South Africa Plasmid Dna Contract Manufacturing Market Size & Outlook
Related Markets
South Africa plasmid dna contract manufacturing market highlights
- The South Africa plasmid dna contract manufacturing market generated a revenue of USD 2.5 million in 2023 and is expected to reach USD 8.7 million by 2030.
- The South Africa market is expected to grow at a CAGR of 19.3% from 2024 to 2030.
- In terms of segment, cell & gene therapy was the largest revenue generating application in 2023.
- Cell & Gene Therapy is the most lucrative application segment registering the fastest growth during the forecast period.
Plasmid dna contract manufacturing market data book summary
| Market revenue in 2023 | USD 2.5 million |
| Market revenue in 2030 | USD 8.7 million |
| Growth rate | 19.3% (CAGR from 2023 to 2030) |
| Largest segment | Cell & gene therapy |
| Fastest growing segment | Cell & Gene Therapy |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell & Gene Therapy, Immunotherapy |
| Key market players worldwide | Charles River Laboratories International Inc, Boehringer Ingelheim, Thermo Fisher Scientific Inc, Lonza Group Ltd, Viva Biotech, VGXI, PlasmidFactory, BioCina, TriLink BioTechnologies, Esco Aster |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.8% of the global plasmid dna contract manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa plasmid dna contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 7.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasmid DNA Contract Manufacturing Market Scope
Plasmid DNA Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Esco Aster | View profile | 11-50 | Singapore, Central Region, Singapore, Asia | https://escoaster.com |
| PlasmidFactory | View profile | 11-50 | Bielefeld, Nordrhein-Westfalen, Germany, Europe | https://plasmidfactory.com/ |
| VGXI | View profile | 101-250 | The Woodlands, Texas, United States, North America | https://vgxii.com/ |
| Viva Biotech | View profile | 1001-5000 | Shanghai, Shanghai, China, Asia | http://www.vivabiotech.com.cn/ |
| BioCina | View profile | 101-250 | Thebarton, South Australia, Australia, Oceania | https://www.biocina.com/ |
| TriLink BioTechnologies | View profile | 251-500 | San Diego, California, United States, North America | http://www.trilinkbiotech.com/ |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
South Africa plasmid dna contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna contract manufacturing market will help companies and investors design strategic landscapes.
Cell & gene therapy was the largest segment with a revenue share of 60% in 2023. Horizon Databook has segmented the South Africa plasmid dna contract manufacturing market based on cell & gene therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Factors driving the market are the growing popularity of gene therapy and rising burden of cancer cases. For instance, according to data gathered from the Global Cancer Observatory database of the International Agency for Research on Cancer, in 2020, there were 711,429 cancer deaths and 1.1 million new cancer cases in Africa.
The major cancer subtypes in Africa, according to the researchers, were liver, breast, cervical, prostate, and colorectal. Egypt, Nigeria, and South Africa were among the nations with the highest mortality rate related to cancer in this period.
Recent advancements in sequencing technology along with developments in related domains, such as molecular biology, virology, cancer, & synthetic chemistry, have made it easier to advance gene therapies.
Reasons to subscribe to South Africa plasmid dna contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa plasmid dna contract manufacturing market databook
-
Our clientele includes a mix of plasmid dna contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa plasmid dna contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa plasmid dna contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa plasmid dna contract manufacturing market size, by end user, 2018-2030 (US$M)
South Africa Plasmid DNA Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
